Janux Therapeutics, Inc. (JANX) — SC 13G/A Filings
All SC 13G/A filings from Janux Therapeutics, Inc.. Browse 11 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (11)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Janux Therapeutics Insider Dr. David Campbell Holds 7.0% Stake
— Feb 9, 2024 Risk: low
Dr. David Campbell, a key figure at Janux Therapeutics, Inc., has updated his ownership stake in the company. As of December 31, 2023, he beneficially owns 2,54 -
FMR LLC & Abigail Johnson Maintain 10.117% Stake in Janux Therapeutics
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Janux Therapeutics, Inc. (JANX) to 10.117% -
Bregua Corp. Maintains Significant Stake in Janux Therapeutics
— Feb 1, 2024
Bregua Corporation, a British Virgin Islands entity, filed an amended SC 13G/A on February 1, 2024, indicating its ownership of Janux Therapeutics, Inc. common
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX